BR112014009266B1 - Processos encurtado, biocatalítico e para preparação de ácidos isoxazolil-metóxinicotínicos - Google Patents

Processos encurtado, biocatalítico e para preparação de ácidos isoxazolil-metóxinicotínicos Download PDF

Info

Publication number
BR112014009266B1
BR112014009266B1 BR112014009266-4A BR112014009266A BR112014009266B1 BR 112014009266 B1 BR112014009266 B1 BR 112014009266B1 BR 112014009266 A BR112014009266 A BR 112014009266A BR 112014009266 B1 BR112014009266 B1 BR 112014009266B1
Authority
BR
Brazil
Prior art keywords
formula
compound
solvent
methyl
phenyl
Prior art date
Application number
BR112014009266-4A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112014009266A2 (pt
BR112014009266A8 (pt
Inventor
Stefan Hildbrand
Pascal Dott
Steven Paul Hanlon
Hans Iding
Andrew Thomas
Pius Waldmeier
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of BR112014009266A2 publication Critical patent/BR112014009266A2/pt
Publication of BR112014009266A8 publication Critical patent/BR112014009266A8/pt
Publication of BR112014009266B1 publication Critical patent/BR112014009266B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/05—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in nitriles (3.5.5)
    • C12Y305/05001—Nitrilase (3.5.5.1)

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BR112014009266-4A 2011-10-20 2012-10-17 Processos encurtado, biocatalítico e para preparação de ácidos isoxazolil-metóxinicotínicos BR112014009266B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11185992.2 2011-10-20
EP11185992 2011-10-20
PCT/EP2012/070521 WO2013057123A1 (en) 2011-10-20 2012-10-17 Process for the preparation of isoxazolyl-methoxy-nicotinic acids

Publications (3)

Publication Number Publication Date
BR112014009266A2 BR112014009266A2 (pt) 2017-06-13
BR112014009266A8 BR112014009266A8 (pt) 2020-04-22
BR112014009266B1 true BR112014009266B1 (pt) 2021-05-04

Family

ID=47019026

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014009266-4A BR112014009266B1 (pt) 2011-10-20 2012-10-17 Processos encurtado, biocatalítico e para preparação de ácidos isoxazolil-metóxinicotínicos

Country Status (20)

Country Link
US (1) US8604062B2 (cg-RX-API-DMAC7.html)
EP (1) EP2768827B1 (cg-RX-API-DMAC7.html)
JP (1) JP5923174B2 (cg-RX-API-DMAC7.html)
KR (2) KR102262697B1 (cg-RX-API-DMAC7.html)
CN (1) CN103889978B (cg-RX-API-DMAC7.html)
AR (1) AR088358A1 (cg-RX-API-DMAC7.html)
AU (1) AU2012321095B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014009266B1 (cg-RX-API-DMAC7.html)
CA (2) CA2850440C (cg-RX-API-DMAC7.html)
DK (1) DK2768827T3 (cg-RX-API-DMAC7.html)
ES (1) ES2613802T3 (cg-RX-API-DMAC7.html)
HU (1) HUE031276T2 (cg-RX-API-DMAC7.html)
IL (1) IL231645A (cg-RX-API-DMAC7.html)
MX (1) MX2014004688A (cg-RX-API-DMAC7.html)
MY (1) MY164880A (cg-RX-API-DMAC7.html)
PL (1) PL2768827T3 (cg-RX-API-DMAC7.html)
RU (1) RU2014118966A (cg-RX-API-DMAC7.html)
SG (1) SG11201401626UA (cg-RX-API-DMAC7.html)
SI (1) SI2768827T1 (cg-RX-API-DMAC7.html)
WO (1) WO2013057123A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7403050B2 (ja) * 2017-08-28 2023-12-22 ユニバーシティ オブ メリーランド ボルチモア 気分障害のための新規ガンマアミノ酪酸型受容体モジュレーター
AU2019286312B2 (en) 2018-06-13 2023-08-17 F. Hoffmann-La Roche Ag New isoxazolyl ether derivatives as GABA A alpha5 PAM
HU231223B1 (hu) 2018-09-28 2022-01-28 Richter Gedeon Nyrt. GABAA A5 receptor modulátor hatású biciklusos vegyületek
US12649738B2 (en) 2020-03-26 2026-06-09 Richter Gedeon Nyrt. 1,3-dihydro-2H-pyrrolo[3,4-c]pyridine derivatives as GABAA α5 receptor modulators
TWI901650B (zh) 2020-03-26 2025-10-21 匈牙利商羅特格登公司 啶及吡啶并〔3,4-c〕嗒衍生物
GB202013765D0 (en) * 2020-09-02 2020-10-14 Gw Res Ltd Method of preparing cannabinoids
CN116854680A (zh) * 2022-03-28 2023-10-10 上海赛默罗生物科技有限公司 异噁唑-杂环类衍生物、药物组合物和用途
CN119265168B (zh) * 2024-11-05 2025-06-20 江南大学 一种新型腈水解酶及其在烟酸生物合成中的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE315033T1 (de) 1998-08-07 2006-02-15 Chiron Corp Subtituierte isoxazole derivate als estrogen rezeptor modulatore
US6551804B2 (en) * 1999-07-12 2003-04-22 E. I. Du Pont De Nemours And Company Process for preparing 4-cyanopentanoic acid
WO2003099793A1 (en) 2002-05-24 2003-12-04 Takeda Pharmaceutical Company Limited 1,2-azole derivatives with hypoglycemic and hypolipidemic activity
GB0221443D0 (en) 2002-09-16 2002-10-23 Glaxo Group Ltd Pyridine derivates
UA82292C2 (uk) * 2004-04-14 2008-03-25 Пфайзер Продактс Инк. Спосіб стереоселективного біоперетворення аліфатичних динітрилів в ціанокарбонові кислоти (варіанти)
CA2564429A1 (en) 2004-05-14 2005-12-01 Irm Llc Compounds and compositions as ppar modulators
PL1802566T3 (pl) 2004-10-01 2009-05-29 Hoffmann La Roche Podstawione heksafluoroizopropanolem pochodne eteru
ATE485269T1 (de) 2005-06-27 2010-11-15 Bristol Myers Squibb Co C-verknüpfte zyklische antagonisten des p2y1- rezeptors mit eignung bei der behandlung thrombotischer leiden
JP2009508905A (ja) 2005-09-19 2009-03-05 エフ.ホフマン−ラ ロシュ アーゲー GABAAα5逆アゴニストとしてのイソオキサゾロ誘導体
CN101277952B (zh) 2005-10-11 2011-09-28 弗·哈夫曼-拉罗切有限公司 异*唑衍生物
RU2426731C2 (ru) 2005-12-23 2011-08-20 Ф. Хоффманн-Ля Рош Аг Производные арил-изоксазоло-4-ил-оксадиазола
US7618973B2 (en) 2007-12-04 2009-11-17 Hoffmann-La Roche Inc. Isoxazolo-pyrazine derivatives
US7943619B2 (en) 2007-12-04 2011-05-17 Hoffmann-La Roche Inc. Isoxazolo-pyridazine derivatives
JP5301557B2 (ja) * 2007-12-04 2013-09-25 エフ.ホフマン−ラ ロシュ アーゲー イソオキサゾロ−ピリジン誘導体
JP2012040448A (ja) * 2008-11-14 2012-03-01 Yasutaka Sakamoto マイクロバブル発生装置
US8222246B2 (en) 2009-04-02 2012-07-17 Hoffmann-La Roche Inc. Substituted isoxazoles
KR101354416B1 (ko) 2009-05-07 2014-02-19 에프. 호프만-라 로슈 아게 감마-아미노부티르산 조절제로서 이속사졸-피리딘 유도체

Also Published As

Publication number Publication date
PL2768827T3 (pl) 2017-05-31
US20130102778A1 (en) 2013-04-25
KR20140084209A (ko) 2014-07-04
ES2613802T3 (es) 2017-05-26
MY164880A (en) 2018-01-30
CN103889978B (zh) 2017-02-15
CA2850440C (en) 2021-05-04
BR112014009266A2 (pt) 2017-06-13
AR088358A1 (es) 2014-05-28
SG11201401626UA (en) 2014-05-29
MX2014004688A (es) 2014-05-28
KR102262697B1 (ko) 2021-06-11
EP2768827A1 (en) 2014-08-27
BR112014009266A8 (pt) 2020-04-22
US8604062B2 (en) 2013-12-10
IL231645A (en) 2016-09-29
AU2012321095A1 (en) 2013-05-09
CA2850440A1 (en) 2013-04-25
IL231645A0 (en) 2014-05-28
DK2768827T3 (en) 2017-02-13
JP2014530831A (ja) 2014-11-20
KR20200008671A (ko) 2020-01-28
WO2013057123A1 (en) 2013-04-25
NZ622214A (en) 2016-08-26
HUE031276T2 (hu) 2017-07-28
SI2768827T1 (sl) 2017-04-26
AU2012321095B2 (en) 2015-08-20
CN103889978A (zh) 2014-06-25
EP2768827B1 (en) 2016-11-23
CA3112072A1 (en) 2013-04-25
JP5923174B2 (ja) 2016-05-24
CA3112072C (en) 2023-06-13
RU2014118966A (ru) 2015-11-27

Similar Documents

Publication Publication Date Title
EP2768827B1 (en) Process for the preparation of isoxazolyl-methoxy-nicotinic acids
ES2833576T3 (es) Inhibidores de glutaminasa novedosos
US10220030B2 (en) Amino-quinolines as kinase inhibitors
CN103797011B (zh) 作为c-Kit激酶抑制剂的化合物和组合物
US20110190279A1 (en) Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity
ES2430223T3 (es) Derivados de isoxazol-piridina como moduladores de GABA
AU664640B2 (en) Phenoxy- and phenoxyalkyl-piperidines as antiviral agents
EA031913B1 (ru) Бициклические гетероциклические производные в качестве ингибиторов irak4
CN105829307A (zh) 用作tnf活性调节剂的四氢咪唑并吡啶衍生物
ES2940695T3 (es) Derivados de piridinilo alcoxi-sustituido como antagonistas del receptor LPA1 y su uso en el tratamiento de la fibrosis
TWI325425B (en) Azaindole-2-carboxamide derivatives
CN114075168A (zh) 一种吡唑衍生物及其在医药上的应用
NZ622214B2 (en) Process for the preparation of isoxazolyl-methoxy-nicotinic acids
HK1193610B (en) Process for the preparation of isoxazolyl-methoxy-nicotinic acids
HK1193610A (en) Process for the preparation of isoxazolyl-methoxy-nicotinic acids
KR20120108056A (ko) (e)-히드록시이미노페닐아세트산 유도체의 제법
WO2005080385A1 (ja) インダノール誘導体

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/10/2012, OBSERVADAS AS CONDICOES LEGAIS.